Patent

This Week on Capitol Hill: Senate Examines Effect of IP on Drug Prices Again, House IP Subcommittee Talks USPTO Oversight

This week on Capitol Hill, the heated drug pricing debate is back in the spotlight, with a Senate Judiciary Committee hearing on intellectual property and the price of prescription drugs on Tuesday. In the House of Representatives, oversight hearings will examine both the activities of the U.S. Patent and Trademark Office and data security efforts made by the Federal Trade Commission. Off the Hill, The Cato Institute looks at U.S. cyber defense capabilities, and the week closes with a Brookings Institution event on China’s actions towards global tech dominance.

Full Article Available Here

Related Posts

No results found

Menu